Prof. Dr. med. Markus Hartenbach

prostate cancer theranostics, nuclear medicine and radiation protection

User Score	Experience	Rating	Price Range	Publications	Media Files	Online Consultations
98%	19 years	9.9/10	$$$$	65	8	No

Overview

Country, City

Austria, Vienna

Health facility

MINUTE Medical Vienna

Medical unit

Department of prostate cancer theranostics, radiopharmaceuticals, and nuclear medicine

About the doctor

Prof. Dr. med. Markus Hartenbach is a highly experienced doctor with 19 years of practice in nuclear medicine and radiation protection. His career highlights include developing advanced imaging techniques for prostate cancer diagnosis and treatment, such as PET/CT and MRI. Dr. Hartenbach's extensive research has led to drug approvals and prestigious awards, showcasing his expertise in the field. His focus on innovative approaches and dedication to improving patient outcomes make him a leader in the medical community. In addition to his impressive career achievements, Dr. Hartenbach is known for his role as Assistant Professor of nuclear medicine at the Medical University of Vienna and as the Divisional Head of the PET/MRI scanner at the Vienna General Hospital. His numerous scientific publications on prostate cancer imaging and treatment demonstrate his commitment to advancing medical knowledge and providing patients with cutting-edge care. Dr. Hartenbach's multidisciplinary approach and expertise in hybrid imaging technologies set him apart as a skilled and forward-thinking medical professional.

Skills & Expertise

Gallery

Resume

CV (Curriculum Vitae)

Education

1998-2005 Studied human medicine at the University of Ulm
Obtaining a license for medical practice
1999 Appointment as a medical officer candidate
1999 Officer courses I and II in Horb am Neckar and Munich
2005-2007 Resident in nuclear medicine at the German Armed Forces Hospital Ulm
2006 Received doctorate from the University of Ulm on the topic: "[11C] choline-PET/CT in primary prostate cancer"
Completed the certification as principal investigator for clinical studies of the competence center clinical trials of the University of Tuebingen
2008-2009 Resident in nuclear medicine at the German Armed Forces Hospital Ulm
2009 Obtaining specialization in radiation protection
2010-2011 Continuing education in PET/CT at the Department of nuclear medicine of the Ludwig-Maximilians-University Munich
2011-2012 Radiology residency at the Armed Forces Hospital Ulm for CT and MRI training
2012 Received additional qualifications in the field of nuclear medicine
2012 Further education in radiology at interdisciplinary PET/CT at the Armed Forces Hospital Ulm

Experience

1998 Military service in Kempten and Munich
2005 Medical Officer of the German Federal Armed Forces
2005-2007 Admitted to the nuclear medicine section of the Armed Forces Hospital Ulm
2007-2008 Science Officer at the Institute for Radiobiology of the German Federal Armed Forces in Munich
2008-2009 Senior Medical Officer in the nuclear medicine section of the Federal Armed Forces Hospital Ulm
2009 Deputy Radiation Protection Officer at the Armed Forces Hospital Ulm
2009 Chief Medical Officer and Deputy Head of nuclear medicine at the Armed Forces Hospital Ulm
2010-2011 Ward Physician at PET/CT of the Department of nuclear medicine of the Ludwig-Maximilians-University Munich
2012 Senior Physician and Deputy Head of the section of nuclear medicine at the Armed Forces Hospital Ulm
2014 Divisional Head of the PET/MRI scanner in the Clinical Department of nuclear medicine at the Vienna General Hospital
2015 Assistant Professor of nuclear medicine at the Medical University of Vienna
2016 Co-founded the Vienna-based Ludwig Boltzmann Institute for Applied Diagnostics

Awards & Memberships

2008 Golden Cross of Honor for the prospective clinical drug study on prostate cancer: "Evaluation of choline positron emission tomography, combined by software fusion with magnetic resonance imaging, in the pre-therapeutic staging of prostate carcinoma"
2010-2013 Developed, applied, and directed the preclinical cooperation project together with the clinic and polyclinic for nuclear medicine at the Ludwig-Maximilians-University Munich: "Multimodal imaging for the detection, localization and prognostic estimation of an exposure by ionizing irradiation"
2012 Nuclear Oncology Council's Young Investigator Award from the Society of Nuclear Medicine
2013 Developed and applied for the prospective randomized clinical trial together with BSM Diagnostika and Siemens Healthineers: "Randomized assessment of patients with clinically suspected prostate cancer after multiparametric metabolic hybrid imaging to evaluate its potential clinical domain"
2014 Achieved the drug approval for [18F] Fluoroethylcholine for prostate cancer imaging (FEC-Max, solution for injection) together with the former company E&Z Radiopharma
2015 Cuno Winkler Prize of the German Society for Nuclear Medicine, the highest prize awarded by the German Society of Nuclear Medicine
2016 Winner of the BSM-Mallinckrodt-Prize of the Austrian Society of Nuclear Medicine and Molecular Imaging
Head of the interdisciplinary working group on prostate cancer hybrid imaging and radionuclide therapy at the Medical University of Vienna